Jonathan E. Lim - Dec 5, 2023 Form 4 Insider Report for Erasca, Inc. (ERAS)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ebun Garner, attorney-in-fact
Stock symbol
ERAS
Transactions as of
Dec 5, 2023
Transactions value $
$1,696,179
Form type
4
Date filed
12/6/2023, 07:41 PM
Previous filing
Oct 10, 2023
Next filing
Feb 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ERAS Common Stock Purchase $1.22M +722K +5.93% $1.69 12.9M Dec 5, 2023 By City Hill, LLC F1, F2
transaction ERAS Common Stock Purchase $478K +278K +2.2% $1.72 12.9M Dec 6, 2023 By City Hill, LLC F1, F2
holding ERAS Common Stock 19.5M Dec 5, 2023 By Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005 F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes purchases made on December 5, 2023, and December 6, 2023 that are reported on this Form 4.
F2 Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.
F3 The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.